Latest headcount
6,400
YoY change
+4.9%
Headcount CAGR
+11.9%
Revenue / employee
$1.89M
Employee count history for Vertex Pharmaceuticals
| Fiscal year | Employees |
|---|---|
| 1998 | 304 |
| 1999 | 353 |
| 2000 | 455 |
| 2001 | 1,000 |
| 2002 | 980 |
| 2003 | 720 |
| 2004 | 736 |
| 2005 | 813 |
| 2006 | 962 |
| 2007 | 1,150 |
| 2008 | 1,333 |
| 2009 | 1,432 |
| 2010 | 1,691 |
| 2011 | 2,000 |
| 2012 | 2,200 |
| 2013 | 1,800 |
| 2014 | 1,830 |
| 2015 | 1,950 |
| 2016 | 2,150 |
| 2017 | 2,300 |
| 2018 | 2,500 |
| 2019 | 3,000 |
| 2020 | 3,400 |
| 2021 | 3,900 |
| 2022 | 4,800 |
| 2023 | 5,400 |
| 2024 | 6,100 |
| 2025 | 6,400 |
Revenue per employee for Vertex Pharmaceuticals
Annual revenue divided by reported headcount, normalized to US dollars.
| Fiscal year | Revenue per employee (USD) |
|---|---|
| 1998 | $146K |
| 1999 | $175K |
| 2000 | $172K |
| 2001 | $167K |
| 2002 | $164K |
| 2003 | $96K |
| 2004 | $140K |
| 2005 | $198K |
| 2006 | $225K |
| 2007 | $173K |
| 2008 | $132K |
| 2009 | $71.3K |
| 2010 | $84.8K |
| 2011 | $705K |
| 2012 | $694K |
| 2013 | $673K |
| 2014 | $317K |
| 2015 | $529K |
| 2016 | $792K |
| 2017 | $1.08M |
| 2018 | $1.22M |
| 2019 | $1.39M |
| 2020 | $1.83M |
| 2021 | $1.94M |
| 2022 | $1.86M |
| 2023 | $1.83M |
| 2024 | $1.81M |
| 2025 | $1.89M |
Earnings per employee for Vertex Pharmaceuticals
Annual net income divided by reported headcount, normalized to US dollars; years with a net loss dip below zero.
| Fiscal year | Earnings per employee (USD) |
|---|---|
| 1998 | -$109K |
| 1999 | -$116K |
| 2000 | -$87.2K |
| 2001 | -$66.2K |
| 2002 | -$111K |
| 2003 | -$273K |
| 2004 | -$226K |
| 2005 | -$250K |
| 2006 | -$215K |
| 2007 | -$340K |
| 2008 | -$345K |
| 2009 | -$448K |
| 2010 | -$446K |
| 2011 | $14.8K |
| 2012 | -$48.7K |
| 2013 | -$247K |
| 2014 | -$404K |
| 2015 | -$286K |
| 2016 | -$52.1K |
| 2017 | $115K |
| 2018 | $839K |
| 2019 | $392K |
| 2020 | $798K |
| 2021 | $601K |
| 2022 | $692K |
| 2023 | $670K |
| 2024 | -$87.8K |
| 2025 | $618K |
Employee count history for Vertex Pharmaceuticals (VRTX)
Annual figures come from annual reports (10-K, or 20-F/40-F for foreign filers); interim rows reflect headcount disclosed in periodic filings. Year-over-year change compares each filing with the prior year's equivalent. Revenue and earnings per employee are annual figures normalized to US dollars.
- 20256,400+4.9%
- 20246,100+13.0%
- 20235,400+12.5%
- 20224,800+23.1%
- 20213,900+14.7%
- 20203,400+13.3%
- 20193,000+20.0%
- 20182,500+8.7%
- 20172,300+7.0%
- 20162,150+10.3%
- 20151,950+6.6%
- 20141,830+1.7%
- 20131,800-18.2%
- 20122,200+10.0%
- 20112,000+18.3%
- 20101,691+18.1%
- 20091,432+7.4%
- 20081,333+15.9%
- 20071,150+19.5%
- 2006962+18.3%
- 2005813+10.5%
- 2004736+2.2%
- 2003720-26.5%
- 2002980-2.0%
- 20011,000+119.8%
- 2000455+28.9%
- 1999353+16.1%
- 1998304—
- 1997220+23.6%
- 1996178—
About Vertex Pharmaceuticals's employee count
Vertex Pharmaceuticals (VRTX) employed 6,400 people in fiscal year 2025, based on its most recent annual report. That headcount grew by +300 (+4.9%) from 6,100 a year earlier.
Across the 1998–2025 period, the company's reported workforce went from 304 to 6,400 employees — a compound annual growth rate (CAGR) of +11.9% per year.
Vertex Pharmaceuticals generated about $1.89M of revenue and $618K of net income per employee in its latest annual period. Revenue and earnings per employee gauge how efficiently a company turns headcount into output, and are most telling when tracked over time or compared with peers in the same industry.
Frequently asked questions
Test yourself on VRTX
Employees — 10 rounds, every one of them VRTX against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.